Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Mismatched HSC Infusion for Relapsed/Refractory AML
NCT03080922Phase 2Unknown
- Sponsor
- 307 Hospital of the People's Liberation Army
- Start
- Mar 2016
- Primary completion
- Mar 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic hematopoietic stem cells in acute myeloid leukemia (AML), sponsored by 307 Hospital of the People's Liberation Army. Status: unknown.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03080922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03080922.